Professor Anthony Warrens
Dean for Education / Director, Institute for Health Sciences Education, Queen Mary University of London
Email: email@example.comTelephone: +44 20 7882 2261Room Number: 1.10 The Garrod Building, Turner Street, Whitechapel, London E1 2AD
Anthony Warrens is Dean for Education and Director of the Institute of Health Sciences Education (IHSE) at Barts and the London School of Medicine and Dentistry (Barts). As Dean, he is responsible for both clinical and non-clinical undergraduate and postgraduate taught programmes in the School and, as Institute Director, he leads the team which develops educational theory and practice at Barts. Since he took up this role in 2010, the standing of the MB BS programme has risen very significantly, a postgraduate course in Physician Associates Studies has been established and, for the first time, the School has developed a range of non-clinical undergraduate programmes. We have developed a branch medical school in the Republic of Malta and are collaborating with colleagues in the Faculty of Science and Engineering in Nanchang in China. IHSE is becoming ever more active in medical education research and has an increasingly large portfolio in educator development.
Before joining Barts, Queen Mary University of London (QMUL), he was Professor of Renal and Transplantation Medicine (a title he continues to hold at QMUL) at Imperial College London. He had first joined one of its predecessor institutes, the Royal Postgraduate Medical School at the Hammersmith Hospital, as a Clinical Training Fellow in 1988. He remained there continuously until moving to QMUL, apart from a post-doctoral fellowship at the Massachusetts General Hospital, part of Harvard Medical School, Boston, USA, in the middle 1990s.
He is a practising consultant renal physician with a particular interest in transplantation medicine. The need for more organs for transplantation, which has been a continuous concern throughout his clinical career, informed his research agenda. He began working on the basic molecular structure of HLA molecules, which are central to the process of graft rejection, and then moved on to consider whether or not non-human organs could provide a viable alternative source of life-saving tissue. He looked at other mechanisms to minimise rejection such as the role of different types of antibody. Working in a culturally heterogeneous community, he also undertook research to understand the impediments to organ donation in various cultures.
He is a former President of the British Transplantation Society and has sat on several governmental bodies developing UK policy and advice on matters relating to transplantation.